Donna ShalalaSell
AXGN Common Stock · Transaction Jun 24, 2019 · Filed Apr 27, 2020 · Amount pending receipt enrichment
XNAS · AXGN
+0.26% · +$0.1300 · Vol Not reported
Pre-market · updated 05:19:05 ET
Axogen, Inc. Common Stock
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$50.53
Veridion Score
BETAMEDIUM CONF · 5/6 factorsFri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET · AXGN
MethodologySentiment absence reason unknown
AXGN
Axogen, Inc. Common Stock
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
59/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is AXGN moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Axogen, Inc. Common Stock
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSListed since
1986
Employees
622
Country
US
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$50.40
Last session
Day high
$50.40
Last session
Day low
$50.40
Last session
Previous close
$50.40
52W high
$50.53
0.00% from high
52W low
$14.79
100% of range
Market cap
$2.7B
EPS
$-0.3900
Beta
0.69
Shares out
53.8M
Avg volume
1.1M
VWAP
$50.40
Last session
Price history computed in-house
1W
+2.81%
1M
+27.96%
3M
+21.91%
1Y
+210.76%
YTD
+54.38%
SMA 50 $44.00 · above
SMA 200 $36.25 · above
52W position 100%
AXGN overview
Related filings and maps
Public disclosures
Congress activity in AXGN
Official filing ↗
AXGN Common Stock · Transaction Apr 16, 2019 · Filed Apr 27, 2020 · Amount pending receipt enrichment
Federal contracts
AXGN contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AXGN in this window.
Lobbying spend
AXGN lobbying filings, year to date.
Registered lobbying filings matched to Axogen, Inc. Common Stock.
$60.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$15.0K
AXOGEN INC.
LKB STRATEGIES LLC
May 8, 2026
Filing
$15.0K
AXOGEN CORPORATION
JEFFREY J. KIMBELL & ASSOCIATES, INC.
Feb 13, 2026
Filing
$15.0K
AXOGEN INC.
LKB STRATEGIES LLC
Feb 6, 2026
Analyst ratings
Sovereign unlock shows live analyst consensus for AXGN.
Options
Sovereign unlock shows live options positioning for AXGN.